Responsible Institution: China Association for Science and Technology
Sponsored by: The Chinese Pharmacological Society
Editor-in-Chief: HUANG Zhili
ISSN 1009-2501
CN 34-1206/R
LIN Qiong-Xia, ZHEN Qiao-Li, XU Lan. Effects and evaluation of misoprostol in hysteroscopy[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(4): 464-466.
1 Rosiing MA, Archbald CD.The knowledge, acceptability, and use of misoprostol for self-induced medical aboration in an urban US population [J].J Am Med Womens Assoc, 2000; (1): 183-5 2 Wu S.Medical aboration in China [J].J Am MedWomens Assoc, 2002; (1):197-200 3 王淑贞.妇产科理论与实践[M].第2 版.上海:上海科学技术出版社, 1991:889-90 4 王恩真.神经外科麻醉学[M].北京:人民卫生出版社,2000:902-3 5 尹敏, 何箐, 彭娟.人工流产中不同镇痛方法效果比较[J].实用妇产科杂志, 1999, 15(5):268-9 6 朱泰丰, 贺昌海, 史益凭, 李腊梅.米索前列醇口服和阴道给药用于宫颈扩张的随机比较实验[J].中国计划生育杂志, 1998;6(2):75-8 7 Bygdeman M, Swahn ML.Uterine contractility and interaction between prostaglandins and antiprogestion:Clinical implications Ann NY[J].Acad Sci, 1991;626:561-7 8 Collins PW.Misoprostol:discovery, development and clinical applications [J].Med Res Rev, 1990;10:149-52 9 He CH, Chen HL, Wang ZX.Study on safety and efficacy of mifepristone plus misoprostol for termination of early pregnancy [J].Reprod Contraception, 1992;3(2):1-3